Privileged structures like Benzothiazole and Pyrrolobenzodiazepine offer wonderful opportunity to explore in anti-cancer drug discovery as a mean to counter drug-resistance problem. BT-PBD hybrids and diverse BT derivatives have been synthesized and their in vitro cytotoxic activities were screened against five cancer cell lines have been discussed. The novel compounds showed promising results as compared
苯并噻唑和
吡咯并苯并二氮杂等特权结构为探索抗癌药物发现提供了绝好的机会,以此作为抗药性问题的手段。已经合成了BT-
PBD杂种和各种BT衍
生物,并讨论了它们针对5种癌
细胞系的体外细胞毒活性。与市售的药物
依托泊苷相比,该新型化合物显示出令人鼓舞的结果,并且可以很好地用于未来的抗癌药物开发研究中。